Endoscopic sleeve gastroplasty: is it time to prioritize minimally invasive interventions for the management of metabolic syndrome?-Reference-Cited by-同舟云学术

Endoscopic sleeve gastroplasty: is it time to prioritize minimally invasive interventions for the management of metabolic syndrome?

Published:2023-02 Issue:2 Volume:85 Page:331-332
ISSN:2049-0801
Container-title:Annals of Medicine & Surgery
language:en
Short-container-title:

Author:

Picón-Jaimes Yelson A.¹,Solano-Ninco María F.²,Rincón-Lozano Zaira Y.³,Ortiz-Rodríguez Marlly G.³,Uribe-Botero Cesar A.⁴,Narvaez-Rojas Alexis R.⁵^ORCID

Affiliation:

1. Fac Ciències Salut Blanquerna, Univ Ramon Llul, Barcelona, Spain

2. School of Medicine, Fundación Universitaria de Ciencias de la Salud

3. School of Medicine, Universidad Cooperativa de Colombia, Villavicencio, Colombia

4. School of Medicine, Pontificia Universidad Javeriana, Bogotá

5. DeWitt Daughtry Family Department of Surgery, Breast Surgical Oncology Division and Jackson Health System/University of Miami Miller School of Medicine, Miami, Florida, USA.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,Surgery

Reference10 articles.

1. Global, regional, and country estimates of metabolic syndrome burden in children and adolescents in 2020: a systematic review and modelling analysis;Noubiap;Lancet Child Adolesc Health,2022

2. Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685 616 adults;Teufel;Lancet,2021

3. Molecular and computational research in low- and middle-income countries: development is close at hand;Pérez-Fontalvo;J Taibah Univ Med Sci,2021

4. Global outcomes, surgical teams and COVID-19 pandemic: will the same objectives of global surgery persist?;Nuñez-Gamez;Ann Med Surg (Lond),2021

5. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial;Abu Dayyeh;Lancet,2022